Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|February 25, 2014
Ran GTPase in nuclear envelope formation and cancer metastasisKyle B Matchett, Suzanne McFarlane, Sophie E Hamilton, et al.International Journal of Pharmaceutics|February 7, 2017
Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cellsYusuf A Haggag, Kyle B Matchett, El-Habib Dakir, et al.Cytokine & Growth Factor Reviews|June 20, 2015
Protein deregulation associated with breast cancer metastasisKa Kui Chan, Kyle B Matchett, Paul M McEnhill, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work BetterPeter J Gawne, Helen E Bryant, Steven G DuBois, et al.Oncotarget|September 11, 2016
Low-dose salinomycin induces anti-leukemic responses in AML and MLLGary D R Roulston, Charlotte L Burt, Laura M J Kettyle, et al.Oncotarget|October 8, 2016
Ran GTPase promotes cancer progression via Met recepto-rmediated downstream signalingHiu-Fung Yuen, Ka-Kui Chan, Angela Platt-Higgins, et al.Life Sciences|July 20, 2023
Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancerMohamed El-Tanani, Angela Platt-Higgins, Hamdi Nsairat, et al.Proceedings of the National Academy of Sciences of the United States of America|May 17, 2020
Tibetan PHD2, an allele with loss-of-function propertiesDaisheng Song, Bradleigh E Navalsky, Wei Guan, et al.Oncotarget|April 19, 2017
Erythropoietin drives breast cancer progression by activation of its receptor EPORKa Kui Chan, Kyle B Matchett, Jonathan A Coulter, et al.British Journal of Haematology|October 7, 2014
Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementationPerry Maxwell, Florinda Melendez-Rodríguez, Kyle B Matchett, et al.Pageof 3